…
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2026-01-31 | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-01-31 | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
| Income before tax | 1194.51M | 919.38M | 588.02M | 509.10M | 512.31M |
| Net income | 908.91M | 714.14M | 525.71M | 487.71M | 427.39M |
| Selling general administrative | 300.74M | 265.74M | 246.54M | 217.59M | 171.51M |
| Selling and marketing expenses | 428.80M | 396.73M | 381.47M | 348.69M | 288.06M |
| Gross profit | 2413.29M | 2046.98M | 1686.38M | 1545.65M | 1347.10M |
| Reconciled depreciation | 37.97M | 39.38M | 32.63M | 29.12M | 27.45M |
| Ebit | 1194.51M | 919.38M | 588.02M | 459.09M | 505.50M |
| Ebitda | 1244.98M | 958.76M | 620.65M | 488.21M | 532.94M |
| Depreciation and amortization | 50.47M | 39.38M | 32.63M | 29.12M | 27.45M |
| Operating income | 916.37M | 691.43M | 429.33M | 459.09M | 505.50M |
| Other operating expenses | 2278.94M | 2055.18M | 1934.34M | 1695.97M | 1345.28M |
| Interest expense | - | - | - | -50.01M | 14.73M |
| Tax provision | 285.60M | 205.24M | 62.32M | 21.39M | 84.92M |
| Interest income | 267.22M | 207.99M | 133.75M | 45.86M | 14.73M |
| Net interest income | 267.22M | 207.99M | 133.75M | 45.86M | 14.73M |
| Income tax expense | 285.60M | 205.24M | 62.32M | 21.39M | 84.92M |
| Total revenue | 3195.31M | 2746.62M | 2363.67M | 2155.06M | 1850.78M |
| Total operating expenses | 1496.92M | 1355.55M | 1257.05M | 1086.56M | 841.60M |
| Cost of revenue | 782.02M | 699.64M | 677.29M | 609.40M | 503.68M |
| Total other income expense net | 278.14M | 227.95M | 158.69M | 50.01M | 6.82M |
| Net income from continuing ops | 908.91M | 714.14M | 525.71M | 487.71M | 427.39M |
| Net income applicable to common shares | - | - | - | 487.71M | 427.39M |
| Breakdown | 2026-01-31 | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-01-31 | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
| Total assets | 8979.34M | 7339.76M | 5910.92M | 4804.30M | 3816.47M |
| Intangible assets | 30.31M | 44.46M | 63.02M | 82.48M | 101.94M |
| Other current assets | 126.47M | 101.46M | 86.92M | 81.46M | 36.68M |
| Total liab | 1764.59M | 1507.38M | 1266.10M | 1088.04M | 904.83M |
| Total stockholder equity | 7214.75M | 5832.37M | 4644.82M | 3716.25M | 2911.64M |
| Deferred long term liab | - | - | - | 31.82M | 33.11M |
| Other current liab | 91.74M | 74.99M | 68.78M | 84.53M | 77.70M |
| Common stock | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Capital stock | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Retained earnings | 4363.50M | 3454.59M | 2740.46M | 2214.75M | 1727.05M |
| Other liab | - | - | - | 31.57M | 20.44M |
| Good will | 439.88M | 439.88M | 439.88M | 439.88M | 439.88M |
| Other assets | - | - | 0.00M | 207.48M | 63.33M |
| Cash | 1421.23M | 1118.79M | 703.49M | 886.47M | 1138.04M |
| Total current liabilities | 1637.06M | 1398.40M | 1178.88M | 1006.80M | 840.78M |
| Current deferred revenue | 1488.82M | 1273.98M | 1049.76M | 869.28M | 731.75M |
| Net debt | -1325.37M | -1043.01M | -647.71M | -825.49M | -1083.45M |
| Short term debt | 12.15M | 9.97M | 9.33M | 11.31M | 10.98M |
| Short long term debt total | 95.86M | 75.78M | 55.77M | 60.98M | 54.59M |
| Other stockholder equity | 2843.09M | 2386.19M | 1915.00M | 1532.63M | 1196.55M |
| Property plant equipment | - | - | - | 105.15M | 104.14M |
| Total current assets | 7997.63M | 6308.80M | 5003.21M | 3969.31M | 3107.18M |
| Net tangible assets | - | - | - | 3193.90M | 2369.82M |
| Short term investments | 5139.58M | 4031.44M | 3324.27M | 2216.16M | 1238.06M |
| Net receivables | 1310.35M | 1057.12M | 888.54M | 785.23M | 694.40M |
| Accounts payable | 37.64M | 30.45M | 31.51M | 41.68M | 20.35M |
| Accumulated other comprehensive income | 8.16M | -8.42M | -10.64M | -31.13M | -11.96M |
| Non currrent assets other | 92.22M | 82.92M | 67.22M | 70.78M | 58.23M |
| Non current assets total | 981.71M | 1030.95M | 907.71M | 834.98M | 709.28M |
| Capital lease obligations | 95.86M | 75.78M | 55.77M | 60.98M | 54.59M |
| Breakdown | 2026-01-31 | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-01-31 | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
| Investments | -1075.23M | -700.14M | -1076.35M | -1007.68M | -324.16M |
| Change to liabilities | - | - | - | 161.90M | 113.15M |
| Total cashflows from investing activities | -1104.36M | -700.14M | -1076.35M | -1007.68M | -346.15M |
| Net borrowings | - | - | 0.00M | - | -0.38M |
| Total cash from financing activities | -9.33M | 26.11M | -16.19M | -19.38M | -4.14M |
| Change to operating activities | - | - | - | -60.66M | -14.68M |
| Net income | 908.91M | 714.14M | 525.71M | 487.71M | 427.39M |
| Change in cash | 302.45M | 414.29M | -182.98M | -251.57M | 409.51M |
| Begin period cash flow | 1120.96M | 706.67M | 889.65M | 1141.22M | 731.71M |
| End period cash flow | 1423.41M | 1120.96M | 706.67M | 889.65M | 1141.22M |
| Total cash from operating activities | 1415.22M | 1090.05M | 911.34M | 780.47M | 764.46M |
| Depreciation | 50.47M | 50.93M | 37.15M | 29.12M | 27.45M |
| Other cashflows from investing activities | -29.13M | -20.52M | -26.20M | - | - |
| Change to account receivables | -254.55M | -168.97M | -104.00M | -72.18M | -67.02M |
| Sale purchase of stock | -169.95M | 0.00M | -78.88M | - | - |
| Other cashflows from financing activities | -93.25M | -79.42M | -78.88M | -19.38M | -3.76M |
| Change to netincome | - | - | - | 234.21M | 262.91M |
| Capital expenditures | 29.13M | 20.52M | 26.20M | 2.49M | 2.49M |
| Change in working capital | -91.94M | 7.62M | 60.82M | 7.34M | 20.66M |
| Stock based compensation | 472.70M | 437.35M | 393.73M | 351.91M | 234.64M |
| Other non cash items | 9.99M | 429.64M | 393.03M | 31.90M | 43.25M |
| Free cash flow | 1386.09M | 1069.53M | 885.14M | 777.98M | 761.97M |
Sector: Healthcare Industry: Health Information Services
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems Inc Class A |
-0.53 0.17% |
310.10 | 43.49 | 29.59 | 12.48 | 5.79 | 10.39 | 33.41 |
| PMCUF Pro Medicus Limited |
- -% |
132.14 | 64.90 | 90.91 | 49.11 | 38.05 | 65.12 | 83.47 |
| TEM Tempus AI, Inc. Class A Common Stock |
-5.18 6.85% |
70.43 | - | - | 8.68 | 25.39 | 8.33 | - |
| MTHRY M3 Inc |
0.68 13.05% |
5.89 | 31.84 | 26.25 | 0.05 | 4.60 | 0.04 | 0.12 |
| BTSG BrightSpring Health Services, Inc. Common Stock |
-3.94 5.64% |
65.86 | 100.22 | 40.65 | 0.69 | 4.92 | 0.92 | 25.80 |
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
| Name | Title | Year Born |
|---|---|---|
| Mr. Peter P. Gassner | Founder, CEO & Director | 1965 |
| Mr. Thomas D. Schwenger | Pres & COO | 1968 |
| Mr. Brent R. Bowman | Chief Financial Officer | 1967 |
| Mr. Alan V. Mateo | Exec. VP of Global Sales | 1962 |
| Ms. Michele O'Connor | Chief Accounting Officer | 1977 |
| Mr. Pinal Patel | Chief Information Officer | NA |
| Mr. Ato Garrett | Sr. Director of Investor Relations | NA |
| Mr. Jonathan W. Faddis | Sr. VP, Gen. Counsel & Corp. Sec. | 1972 |
| Mr. Jacques Mourrain Ph.D. | VP of Quality & Compliance | NA |
| Ms. Eleni Nitsa Zuppas | Chief Marketing Officer | 1970 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.